Jeffrey L. Cleland

President & Chief Executive Officer at Ilypsa, Inc.

Jeffrey L. Cleland

Jeffrey L. Cleland

President & Chief Executive Officer at Ilypsa, Inc.

Overview
Career Highlights

Ilypsa, Inc.
Ashvattha Therapeutics LLC
Graybug Vision, Inc.

RelSci Relationships

2175

Number of Boards

10

Birthday

1965

Age

55

Relationships
RelSci Relationships are individuals Jeffrey L. Cleland likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Partner at Hatteras Venture Partners

Relationship likelihood: Strong

Director-NanoMedicine Center at The Wilmer Eye Institute at Johns Hopkins

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at Horizon Therapeutics Plc

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Aravive, Inc.

Relationship likelihood: Strong

Chief Technology Officer at Orpheris, Inc.

Relationship likelihood: Strong

Senior Vice President at Falcon Laboratory Ltd.

Relationship likelihood: Strong

Former Chief Business Officer at Versartis, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Exicure Operating Co.

Relationship likelihood: Strong

Co-Founder at Graybug Vision, Inc.

Relationship likelihood: Strong

Co-Founder at Graybug Vision, Inc.

Relationship likelihood: Strong

Paths to Jeffrey L. Cleland
Potential Connections via
Relationship Science
You
Jeffrey L. Cleland
President & Chief Executive Officer at Ilypsa, Inc.
Education
Memberships
Member
Current

The American Chemical Society (ACS) encourages the broadest and most liberal manner the advancement of chemistry in all its branches, the promotion of research in chemical science and industry, the improvement of the qualifications and usefulness of chemists through high standards of professional ethics, education, and attainments, the increase and diffusion of chemical knowledge, and by its meetings, professional contacts, reports, papers, discussions, and publications.

Member
Current

American Institute of Chemical Engineers is an American private company located in New York, NY, with operations in the United States, that operates as a professional organization for chemical engineers.The company says this about itself: AIChE is a professional society of more than 53,000 chemical engineers in 110 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontiers of chemical engineering research in such areas as energy, sustainability, biological and environmental engineering, nano technology, and chemical plant safety and security.

Member
Current

CRS is the home for experts dedicated to the delivery of actives, including delivery scientists, engineers, clinicians, and technical professionals. CRS members are creating the future of delivery science and technology through fundamental delivery research, development, regulatory science, and clinical translation. Research published in CRS journals and presented during the Annual Meeting & Exposition offer a breadth of scientific knowledge covering new technologies and science in the multi-disciplinary delivery field.

Career History
Co-Founder
2015 - Current

Orpheris, Inc. provides healthcare services. The firm focused on the treatment of neuroinflammatory orphan diseases. The company was founded was founded in 2015 and is headquartered in Redwood City, CA.

President & Chief Executive Officer
Current

Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.

Executive Chairman, President & Chief Executive Officer
Current

Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA.

Boards & Committees
Member, Board of Directors
2015 - Current
Chief Executive Officer & Director
2010 - 2013
Transactions
Details Hidden

Graybug Vision, Inc. raised money in a private placement transaction

Details Hidden

Graybug Vision, Inc. raised money in a private placement transaction

Details Hidden

Versartis, Inc. raised money in a private placement transaction

Investments
Details Hidden

Orpheris, Inc. provides healthcare services. The firm focused on the treatment of neuroinflammatory orphan diseases. The company was founded was founded in 2015 and is headquartered in Redwood City, CA.

Details Hidden

Diartis Pharmaceuticals, Inc. developed therapeutic proteins for the treatment of metabolic disorders. The company was founded by Jeffrey L. Clearland in December 2010 and headquartered in Redwood City, CA.

Details Hidden

Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jeffrey L. Cleland. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jeffrey L. Cleland's profile does not indicate a business or promotional relationship of any kind between RelSci and Jeffrey L. Cleland.